AIC
CDTX

AWM Investment Company’s Cidara Therapeutics CDTX Stock Holding History

AWM Investment Company’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-13,133
Closed -$2.73M – 97
2016
Q4 		$2.73M Hold
13,133
– – 0.54% 56
2016
Q3 		$3.01M Hold
13,133
– – 0.55% 56
2016
Q2 		$2.71M Sell
13,133
-117
-0.9% -$28.3K 0.58% 53
2016
Q1 		$3.37M Buy
13,250
+5,750
+77% +$1.33M 0.71% 44
2015
Q4 		$2.57M Buy
7,500
+880
+13% +$264K 0.51% 50
2015
Q3 		$1.68M Buy
6,620
+4,116
+164% +$1.18M 0.33% 72
2015
Q2 		$702K Buy
+2,504
New +$770K 0.1% 109

Other funds holding CDTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AWM Investment Company's CDTX Position: Q1 2017 in Review

AWM Investment Company sold out of Cidara Therapeutics (CDTX) in Q1 2017, closing a stake of 13,133 shares — an estimated $2.73M sold.

AWM Investment Company first reported a position in CDTX in Q2 2015 and held it in 7 quarters. The position peaked at $3.37M in Q1 2016. 54 funds tracked by Wall St. Rank hold CDTX as of Q1 2017.

  • AWM Investment Company reported no remaining Cidara Therapeutics position as of Q1 2017 after selling out during the quarter.
  • AWM Investment Company sold 13,133 Cidara Therapeutics shares in Q1 2017, an estimated $2.73M.
  • AWM Investment Company first reported a position in Cidara Therapeutics in Q2 2015 and held it in 7 quarters.
  • AWM Investment Company's Cidara Therapeutics position peaked at $3.37M in Q1 2016.
  • 54 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2017.

Based on AWM Investment Company's 13F filing for Q1 2017, filed 12 May 2017.